Area of research
Oncology · Molecular Biology
Research interest
Research interests include Chemistry, Synthetic lethality, Olaparib, Wee1, DNA damage, and CHEK1.
Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies
Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020–2024)
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents